- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT02283021
Expression and Sequence of Calcium Channels in Non-small Cell Lung Carcinoma (NSCLC)
Calcium is an extremely important ion used in our body for many processes. One of its tasks is to control gene expression. Cells intake calcium from their surroundings though special calcium channels located on the surface membranes of the cells.
The great many studies on such calcium channels were performed on excitable cells such as muscle, heart or neuronal cells, where the calcium ions are controlled by voltage. Surprisingly, not much is known about the identity of calcium subunits in non-excitable cells like epithelial cells (which compose most of the connective tissue in the body), liver cells, lung cells, immune system cells, etc.
Recently, the investigators have shown that calcium channels from muscles are, in fact, expressed in T cells of the immune system, where they are used for proliferation. The investigators postulated that probably other cell types, especially cancerous cell types, might be using these subunits similarly.
The aim of this study is to determine the identity and sequence of calcium subunits expressed in non-small cell Lung Carcinoma (NSCLC), which accounts for 80% of the worldwide lung cancer deaths.
연구 개요
상세 설명
Initial examination of NSCLC cell lines determined that they express the mRNA of voltage gated calcium subunits, found normally in neurons. Furthermore sequence analysis of these subunits has shown that modifications have occurred.
The aim of the study in NSCLC patients is to sequence and clone the calcium channel subunits expressed in their tumor. Expression and Sequence will be compared between the normal and cancerous lung tissue for each patient.
연구 유형
등록 (예상)
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
설명
Inclusion Criteria:
- NSCLC patients
- Patients without NSCLC
- Men or woman between 18-80 years of age
Exclusion Criteria:
- Pregnant woman
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
---|---|
NSCLC Patients
Sample biopsies from normal and cancerous lung tissue.
|
Sample tissue will be obtained from the routine biopsy taken for pathological evaluation.
A pathologist will determine which part of the tissue will be forwarded for this study, to avoid any interference with the pathological evaluation.
|
Patients without NSCLC
Sample biopsies from normal lung tissue.Control group.
|
Sample tissue will be obtained from the routine biopsy taken for pathological evaluation.
A pathologist will determine which part of the tissue will be forwarded for this study, to avoid any interference with the pathological evaluation.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
mRNA expression and sequence of calcium channel subunits in NSCLC
기간: up to 1 month per patient
|
mRNA will be extracted from each sample biopsy followed by real time PCR analysis.
If any calcium subunit is detected, semi quantitative PCR will be performed, PCR bands will be cloned and sequenced.
|
up to 1 month per patient
|
공동 작업자 및 조사자
수사관
- 연구 책임자: Hadas Lamberg, PhD, Hadassah Medical Organization
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (예상)
연구 완료 (예상)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
NSCLC에 대한 임상 시험
-
Centre Oscar LambretUniversity Hospital, Lille종료됨
-
Suzhou Zelgen Biopharmaceuticals Co.,Ltd완전한
-
Fondazione Policlinico Universitario Agostino Gemelli...완전한
-
Spanish Lung Cancer Group완전한